NHF is expanding its work with the bleeding disorders community around the world.
The designation is for people with hemophilia A without inhibitors.
The company donated over 25 million international units (IU) of factor products used to treat hemophilia A and B.
ICER is an independent and non-partisan research organization that evaluates the clinical and economic value of prescription drugs, medical tests, and other healthcare and healthcare delivery innovations.
Val D. Bias spoke to the leaders of NHF’s 52-chapter networks at the NHF 2018 Chapter Leadership Seminar in San Francisco, California.
Applications are now open! The selected KCS recipient will receive an award of $1,000 toward their tuition costs.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car